SIEGEL , D. .; MURPHY , C.; WANGSNESS, K.; PERRY , A. .; SMITH , I. . Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. 109–121, 2022. DOI: 10.25251/skin.6.2.4. Disponível em: https://jofskin.org/index.php/skin/article/view/1475. Acesso em: 12 aug. 2022.